Lab in the Time of Coronavirus: “Harnessing Antibodies”
As the world waits for a COVID-19 vaccine, researchers in New York are developing a way to treat people who have the virus with antibodies collected from those who have recovered.
Professor of Biochemistry and Molecular Biophysics and Ophthalmic Science (in Ophthalmology and in the Naomi Berrie Diabetes Center); Principal Investigator at Columbia's Zuckerman Institute
As the world waits for a COVID-19 vaccine, researchers in New York are developing a way to treat people who have the virus with antibodies collected from those who have recovered.
Clark AJ, Gindin T, Zhang B, Wang L, Abel R, Murret CS, Xu F, Bao A, Lu NJ, Zhou T, Kwong PD,
, Honig B, Friesner RAJ Mol Biol.2016 Nov 28
Goodman KM, Rubinstein R, Thu CA, Mannepalli S, Bahna F, Ahlsén G, Rittenhouse C, Maniatis T, Honig B,
Elife.2016 Oct 26
Goodman KM, Yamagata M, Jin X, Mannepalli S, Katsamba PS, Ahlsén G, Sergeeva AP, Honig B, Sanes JR,
Elife.2016 Sep 19
Harrison OJ, Brasch J, Lasso G, Katsamba PS, Ahlsen G, Honig B,
Proc Natl Acad Sci U S A.2016 Jun 28
Goodman KM, Rubinstein R, Thu CA, Bahna F, Mannepalli S, Ahlsén G, Rittenhouse C, Maniatis T, Honig B,
Neuron.2016 May 18